| Tillotts Pharma AG - Yaldigo 400 mg, magensaftresistente Tablette | | 53108 | | 01 | | Yaldigo 400 mg | | magensaftresistente Tablette | | A07EC02 | | Mesalazine | | 15.11.1994 | | |
| | Composition | | mesalazinum 400 mg, lactosum monohydricum 76.4 mg, carboxymethylamylum natricum A corresp. natrium 0.768 mg, magnesii stearas, talcum, povidonum K 25, Überzug: acidi methacrylici et methylis methacrylatis polymerisatum 1:2, talcum, triethylis citras, macrogolum 6000, E 172, pro compresso obducto. | | Packungsbestandteile | | Gastric juice resistant tablets | | | | Active Agent | Dose |
|---|
| Mesalazine | 400 mg |
| | | | Inactive agents | Dose | additional_information |
|---|
| Acidi Methacrylici | | Überzug | | Carboxymethylamylum Natricum A | | | | E 172 | | color. | | Lactose Monohydrate | 76.4 mg | | | Macrogol | 6000 | | | Magnesii Stearas | | | | Methylis Methacrylatis Polymerisatum | | | | Povidonum K | 25 | | | Pro Compresso Obducto | | | | Talcum | | | | Triethylis Citras | | |
|
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 004 | 100 | PR | PR | B | | Yes |
|
|
